24 May 2013
Keywords: genzyme, synvisc-one, awarded, eu, ce, mark, biotechnology
Article | 24 December 2007
US biotechnology major Genzyme has been granted European approval through a CE mark for Synvisc-One, the single treatment of Synvisc ( ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.